 A scientific workshop will feature Dr. Rashmi Kanagal-Shamanna from the University of Texas MD Anderson Cancer Center delivering a presentation on the use of emerging technologies for prognostication and research into myeloid neoplasms Four scientific posters featuring results from OGM applications in myeloid cancers, acute lymphoblastic leukemia ALL, myelodysplastic syndromes MDS and hematological malignancy research, ... The post Bionano Genomics Announces American Society of Hematology A... 